Brandon Researcher Recognized for Breakthrough Breast Cancer Test

Mousumi Majumder, a researcher at Brandon University, received recognition from the Manitoba Legislature for her innovative work on a blood test aimed at early detection of breast cancer. The acknowledgment, delivered through a Member’s Statement by Glen Simard, the MLA for Brandon East, occurred during Breast Cancer Awareness Month. Simard emphasized that Majumder’s research offers “hope to families here in Manitoba and around the world.”

Majumder, who holds a Canada Research Chair (Tier II) in Genotoxicology, has been at Brandon University since 2016. Her research team has made significant strides in identifying microRNAs—small RNA molecules that can act as biomarkers for early cancer detection. This work aims to develop a non-invasive blood test that could complement existing mammogram screenings, potentially identifying breast cancer at an earlier stage when treatment is most effective.

The recognition from the provincial legislature was unexpected for Majumder. “For researchers, publishing in top journals or securing competitive grants is usually what we consider recognition, but this was great,” she shared. Initially, she thought an email from the minister’s office was a scam, given that it had landed in her spam folder. “When I finally called and they said, ‘Dr. Majumder, we’ve been desperately trying to reach you,’ that’s when it hit me,” she recalled, expressing her disbelief at the honor.

During her visit to the legislature, Majumder was touched by the warm reception from the MLAs, many of whom were alumni of Brandon University. “They treated me like a celebrity,” she said, highlighting the respect and recognition her work garnered.

Majumder believes the recognition reflects not only her efforts but also those of her students and trainees. “This happened because of my students. They bring their skills and dedication every day,” she emphasized, stating that she represents the collective effort of her lab members, past, present, and future.

Her ongoing research is focused on detecting molecular markers in blood samples that can indicate breast cancer even before physical symptoms or abnormal imaging results appear. “Our goal isn’t to replace mammograms but to support them,” she explained. The ability to identify cancer signatures in blood could allow for earlier alerts to doctors and better support for patients, including younger women who may not yet qualify for routine screening.

Majumder’s preliminary findings suggest that certain microRNAs can detect breast cancer as early as stage one, which could significantly change the landscape of early diagnosis. However, she noted the necessity for larger sample sizes and stable funding to continue her research. “We’ve analyzed about 300 samples, but to fully validate our results, we need around 3,000 samples,” she stated, identifying the next major challenge ahead.

Simard highlighted the broader implications of Majumder’s work, particularly for Manitobans living in rural and remote areas who often face obstacles to accessing cancer screening services. “Combined with the lowering of the screening age and breakthroughs in early detection, Manitobans no longer need to equate travel with receiving lifesaving breast cancer services,” he noted.

Majumder expressed gratitude to her university and colleagues, stating, “I see myself as only a researcher. But this honour reflects years of hard work and the collective spirit of Brandon University. We are truly humbled and grateful.”